In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 pill to identify Risk-free dosing program. Extra members will be enrolled with the discovered monotherapy dosign program. In Segment B, individuals will receive oral ruxolitinib and ABBV-744 are going to be provided as "incorporate-on" therapy. In Section https://traudls999fqb2.blogpixi.com/profile